Related Experiment Video
Updated: Mar 7, 2026
03:50
Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment
Published on: August 2, 2024
2.2K
Extracorporeal Shock Wave Therapy: Current Perspectives and Future Directions
Andrew C Lawler1, Eric M Ghiraldi2, Carmen Tong2
1Philadelphia College of Osteopathic Medicine, Philadelphia, PA, 19131, USA.
Current Urology Reports
|March 2, 2017
Summary
Extracorporeal shock wave lithotripsy (ESWL) remains a key treatment for urolithiasis. Advances in technology and patient selection have improved its effectiveness and reduced complications, solidifying its role in stone disease management.
Area of Science:
- Urology
- Nephrology
- Medical Technology
Background:
- Extracorporeal shock wave lithotripsy (ESWL) is a widely used treatment for urolithiasis.
- ESWL has evolved significantly since its introduction.
- Its cost-effectiveness and healthcare outcomes are under continuous review.
Purpose of the Study:
- To update urologists on current trends in ESWL.
- To review new technologies and controversies in ESWL for stone treatment.
Main Methods:
- Review of contemporary trends in ESWL.
- Analysis of technological advancements in lithotripters.
- Evaluation of patient and stone selection criteria.
Main Results:
- Lithotripter technology has advanced, improving stone-free rates and reducing complications.
- Enhanced patient selection has led to better procedural success.
- Optimized techniques and stringent selection criteria maintain ESWL's efficacy.
Conclusions:
- ESWL remains a primary treatment modality for urolithiasis.
- Technological progress and refined patient selection enhance ESWL outcomes.
- Continued optimization ensures ESWL's place in stone disease management.
